ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,392Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 1185

$904K Total Retail Price of All Prescriptions

Rank: 56 out of 1185

627 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 627 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

29% of this provider’s 627 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 12,014 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
HYDROCODONE-ACETAMINOPHEN 1,084 537 S3 1 2
SIMVASTATIN 608 429 2 5
OMEPRAZOLE 602 410 3 6
AMLODIPINE BESYLATE 520 416 4 1
LISINOPRIL 438 277 5 4
LEVOTHYROXINE SODIUM 422 299 6 3
FUROSEMIDE 388 303 7 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 329 208 8 14
MELOXICAM 281 183 9 27
METOPROLOL SUCCINATE 269 207 10 20
HYDROCHLOROTHIAZIDE 268 160 11 12
METFORMIN HCL ER 265 197 12 35
METOPROLOL TARTRATE 262 192 13 10
POTASSIUM CHLORIDE 261 181 14 18
NAMENDA 238 238 15 43
TRAMADOL HCL 229 176 16 16
WARFARIN SODIUM 228 170 17 21
AMLODIPINE BESYLATE-BENAZEPRIL 228 175 17 42
NEXIUM 222 121 19 19
SERTRALINE HCL 210 123 20 25
LOSARTAN-HYDROCHLOROTHIAZIDE 197 157 21 36
ATORVASTATIN CALCIUM 195 146 22 11
DONEPEZIL HCL 182 173 23 32
CYMBALTA 175 64 24 44
CARVEDILOL 159 113 25 24
ALLOPURINOL 158 136 26 30
ESCITALOPRAM OXALATE 143 135 27 79
TAMSULOSIN HCL 142 117 28 34
GABAPENTIN 141 89 29 13
CRESTOR 135 65 30 23
CITALOPRAM HBR 134 99 31 22
GLIMEPIRIDE 132 122 32 49
PRAVASTATIN SODIUM 131 98 33 7
METFORMIN HCL 125 64 34 9
MIRTAZAPINE 125 105 34 57
FAMOTIDINE 118 94 36 69
DIOVAN HCT 117 92 37 46
ZOLPIDEM TARTRATE 117 56 37 15
CLOPIDOGREL 117 69 37 31
KLOR-CON M20 111 81 40 59
FLUOXETINE HCL 111 53 40 52
EXELON 105 105 42 120
AMITRIPTYLINE HCL 100 57 R 43 51
PLAVIX 99 71 44 45
PROAIR HFA 99 60 44 50
DIGOXIN 96 81 46 67
CIPROFLOXACIN HCL 91 80 47 62
TRAZODONE HCL 91 38 47 38
KLOR-CON 10 90 90 49 118
RANITIDINE HCL 89 55 50 17
LOSARTAN POTASSIUM 89 61 50 26
ATENOLOL 89 75 50 28
POLYETHYLENE GLYCOL 3350 88 61 53 60
FLUTICASONE PROPIONATE 85 47 54 29
ISOSORBIDE MONONITRATE ER 84 73 55 48
DIVALPROEX SODIUM 83 82 56 96
VENLAFAXINE HCL ER 81 49 57 105
PREDNISONE 79 52 58 33
PHENYTOIN SODIUM EXTENDED 76 68 59 111
VESICARE 76 38 59 200
CYCLOBENZAPRINE HCL 76 18 R 59 53
ALENDRONATE SODIUM 75 69 62 40
ADVAIR DISKUS 75 53 62 54
PRAMIPEXOLE DIHYDROCHLORIDE 75 40 62 185
OXYCODONE HCL 74 0 S2 65 70
CLONIDINE HCL 72 50 66 47
RAMIPRIL 71 35 67 135
PAROXETINE HCL 68 43 68 73
HUMALOG MIX 75-25 68 50 68 239
INSULIN SYRINGE 66 37 70 90
CELEBREX 66 38 70 85
CARISOPRODOL 65 0 R 72 87
JANUVIA 65 48 72 68
LANTUS 65 43 72 66
BENAZEPRIL HCL 64 48 75 41
RISPERIDONE 63 57 76 72
DICLOFENAC SODIUM 61 20 77 81
AMOX TR-POTASSIUM CLAVULANATE 56 39 78 140
LYRICA 56 31 78 74
LANSOPRAZOLE 53 34 80 216
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.